BioSpace News Archive

Century Therapeutics, (NASDAQ: IPSC), an innovative biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies in immuno-oncology, today reported financial results and business highlights for the second quarter ended June 30, 2021.

F-star Therapeutics, Inc. (NASDAQ: FSTX), a clinical-stage biopharmaceutical company dedicated to developing next generation bispecific immunotherapies to transform the lives of patients with cancer, today announces second quarter 2021 financial results and provides a corporate update.

Pharma Two B Ltd., a privately held company developing innovative therapeutics based on previously approved drugs for Parkinson disease (PD), today announced the appointment of Jeffrey Berkowitz as Chairman of its Board of Directors, effective immediately.

Shanghai Junshi Biosciences Co., Ltd and Coherus BioSciences, Inc. today announced that the United States Food and Drug Administration (“FDA”) has recently granted Breakthrough Therapy Designation (“BTD”) for toripalimab in combination with chemotherapy (gemcitabine and cisplatin) for the 1 st line treatment of recurrent or metastatic nasopharyngeal carcinoma.

Global Blood Therapeutics, Inc. announced that on August 1, 2021, the compensation committee of GBT’s board of directors granted 12 new employees restricted stock units for an aggregate of 33,050 shares of the company’s common stock.

Rentschler Biopharma, a leading global contract development and manufacturing organization for biopharmaceuticals, announced that the company has broken ground at its new production site, adjacent to its existing site in Milford, MA in the greater Boston area.

Kintara Therapeutics, Inc announced today that its Chief Executive Officer, Saiid Zarrabian , will present at the Investor Summit Conference being held August 17 – 18, 2021.

Petros Pharmaceuticals, Inc. today announced that President and Chief Commercial Officer Fady Boctor is scheduled to present at the following virtual conferences: Q3 Investor Summit: August 17 – 18, 2021

ProMIS Neurosciences, Inc. today announced its operational and financial results for the three and six months ended June 30, 2021.

Rhythm Pharmaceuticals, Inc. today announced that it will present data from multiple clinical trials at the 59 th Annual European Society for Paediatric Endocrinology (ESPE) Meeting to be held virtually September 22-26, 2021.